Literature DB >> 28741237

Cytotoxic T lymphocytes and CD4 epitope mutations in the pre-core/core region of hepatitis B virus in chronic hepatitis B carriers in Northeast Iran.

Sareh Zhand1, Alijan Tabarraei1, Amineh Nazari2, Abdolvahab Moradi3.   

Abstract

BACKGROUNDS: Hepatitis B virus (HBV) is vulnerable to many various mutations. Those within epitopes recognized by sensitized T cells may influence the re-emergence of the virus. This study was designed to investigate the mutation in immune epitope regions of HBV pre-core/core among chronic HBV patients of Golestan province, Northeast Iran.
METHODS: In 120 chronic HBV carriers, HBV DNA was extracted from blood plasma samples and PCR was done using specific primers. Direct sequencing and alignment of the pre-core/core region were applied using reference sequence from Gene Bank database (Accession Number AB033559).
RESULTS: The study showed 27 inferred amino acid substitutions, 9 of which (33.3%) were in CD4 and 2 (7.4%) in cytotoxic T lymphocytes' (CTL) epitopes and 16 other mutations (59.2%) were observed in other regions.
CONCLUSIONS: CTL escape mutations were not commonly observed in pre-core/core sequences of chronic HBV carriers in the locale of study. It can be concluded that most of the inferred amino acid substitutions occur in different immune epitopes other than CTL and CD4.

Entities:  

Keywords:  CD4 epitope; CTL epitope; HBV; Iran; Pre-core/core mutations

Mesh:

Substances:

Year:  2017        PMID: 28741237     DOI: 10.1007/s12664-017-0767-z

Source DB:  PubMed          Journal:  Indian J Gastroenterol        ISSN: 0254-8860


  21 in total

1.  Acute phase HBV-specific T cell responses associated with HBV persistence after HBV/HCV coinfection.

Authors:  Simona Urbani; Carolina Boni; Barbara Amadei; Paola Fisicaro; Simona Cerioni; Maria Antonietta Valli; Gabriele Missale; Carlo Ferrari
Journal:  Hepatology       Date:  2005-04       Impact factor: 17.425

2.  Reduced hepatitis B virus (HBV)-specific CD4+ T-cell responses in human immunodeficiency virus type 1-HBV-coinfected individuals receiving HBV-active antiretroviral therapy.

Authors:  J Judy Chang; Fiona Wightman; Angeline Bartholomeusz; Anna Ayres; Stephen J Kent; Joseph Sasadeusz; Sharon R Lewin
Journal:  J Virol       Date:  2005-03       Impact factor: 5.103

Review 3.  Immunology of hepatitis B infection.

Authors:  Maria-Christina Jung; Gerd R Pape
Journal:  Lancet Infect Dis       Date:  2002-01       Impact factor: 25.071

4.  Immunogenicity and tolerogenicity of hepatitis B virus structural and nonstructural proteins: implications for immunotherapy of persistent viral infections.

Authors:  Kazuhiro Kakimi; Masanori Isogawa; JoSan Chung; Alessandro Sette; Francis V Chisari
Journal:  J Virol       Date:  2002-09       Impact factor: 5.103

5.  The prevalence of hepatitis B surface antigen and anti-hepatitis B core antibody in Iran: a population-based study.

Authors:  Shahin Merat; Houri Rezvan; Mehdi Nouraie; Arsia Jamali; Shervin Assari; Hassan Abolghasemi; Amir-Reza Radmard; Hanieh Zaer-Rezaii; Mahmood Zeid-Abadi-Nejhad; Mohammad-Reza Hosseini; Sedigheh Amini-Kafiabad; Mahtab Maghsudlu; Akram Pourshams; Reza Malekzadeh
Journal:  Arch Iran Med       Date:  2009-05       Impact factor: 1.354

6.  Precore codon 28 stop mutation in hepatitis B virus from patients with hepatocellular carcinoma.

Authors:  Y M Park; B S Kim; E Tabor
Journal:  Korean J Intern Med       Date:  1997-06       Impact factor: 2.884

7.  A new unconventional HLA-A2-restricted epitope from HBV core protein elicits antiviral cytotoxic T lymphocytes.

Authors:  Lu Sun; Yu Zhang; Bao Zhao; Mengmeng Deng; Jun Liu; Xin Li; Junwei Hou; Mingming Gui; Shuijun Zhang; Xiaodong Li; George F Gao; Songdong Meng
Journal:  Protein Cell       Date:  2014-03-22       Impact factor: 14.870

8.  The role of mutations in core protein of hepatitis B virus in liver fibrosis.

Authors:  Ashraf Mohamadkhani; Ferdous Rastgar Jazii; Hossein Poustchi; Omidreza Nouraein; Shahsanam Abbasi; Masoud Sotoudeh; Ghodratollah Montazeri
Journal:  Virol J       Date:  2009-11-26       Impact factor: 4.099

9.  Seroprevalence of hepatitis B virus and its co-infection with hepatitis D virus and hepatitis C virus in Iranian adult population.

Authors:  Roshandel Gholamreza; Semnani Shahryar; Keshtkar Abbasali; Joshaghani Hamidreza; Moradi Abdolvahab; Kalavi Khodaberdi; Roshandel Danyal; Abdolahi Nafiseh
Journal:  Indian J Med Sci       Date:  2007-05

10.  Correlation between hepatitis B surface antigen titers and HBV DNA levels.

Authors:  Amal Alghamdi; Nagwa Aref; Malak El-Hazmi; Waleed Al-Hamoudi; Khalid Alswat; Ahmed Helmy; Faisal M Sanai; Ayman A Abdo
Journal:  Saudi J Gastroenterol       Date:  2013 Nov-Dec       Impact factor: 2.485

View more
  1 in total

1.  Molecular Characterization of Near Full-Length Genomes of Hepatitis B Virus Isolated from Predominantly HIV Infected Individuals in Botswana.

Authors:  Motswedi Anderson; Wonderful Tatenda Choga; Sikhulile Moyo; Trevor Graham Bell; Tshepiso Mbangiwa; Bonolo Bonita Phinius; Lynnette Bhebhe; Theresa Kibirige Sebunya; Shahin Lockman; Richard Marlink; Anna Kramvis; Max Essex; Rosemary Mubanga Musonda; Jason Tory Blackard; Simani Gaseitsiwe
Journal:  Genes (Basel)       Date:  2018-09-07       Impact factor: 4.096

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.